| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 03/11/2004 | WO2004020572A2 Bioreactor with expandable surface area for culturing cells |
| 03/11/2004 | WO2004019994A1 Ark5 |
| 03/11/2004 | WO2004019981A1 Method of diffrentiation and maturation of non-nerve cells into nerve cells, agent therefor and method of searching for the agent |
| 03/11/2004 | WO2004019968A1 Methods for preserving organs and tissues |
| 03/11/2004 | WO2004019893A2 Modulators of angiogenesis |
| 03/11/2004 | WO2004019884A2 Agents and methods for enhancing bone formation |
| 03/11/2004 | WO2004019878A2 Adzymes and uses thereof |
| 03/11/2004 | WO2004019872A2 Oral delivery of modified transferrin fusion proteins |
| 03/11/2004 | WO2004019767A2 Heart derived cells for cardiac repair |
| 03/11/2004 | WO2003099862A8 Export and modification of (poly)peptides in the lantibiotic way |
| 03/11/2004 | WO2003097788A3 Cell culture device |
| 03/11/2004 | WO2003091396A3 Polypeptides and biosynthetic pathways |
| 03/11/2004 | WO2003086308A3 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection |
| 03/11/2004 | WO2003080816A3 Stem cell culture |
| 03/11/2004 | WO2003080801A3 Adipose stromal stem cells for tissue and vascular modification |
| 03/11/2004 | WO2003078637A3 Optimizing glycan processing in plants |
| 03/11/2004 | WO2003074563A3 Means and methods for manipulating hypersensitivity-like responses |
| 03/11/2004 | WO2003073912A3 Pre-fabricated tissue-engineered plug |
| 03/11/2004 | WO2003068933A3 Optimization of gene sequences of virus-like particles for expression in insect cells |
| 03/11/2004 | WO2003055974A3 Novel alkaline protease from bacillus sp. (dsm 14392) and washing and cleaning products comprising said novel alkaline protease |
| 03/11/2004 | WO2003054141A3 Sperm-specific cation channel, catsper2, and uses therefor |
| 03/11/2004 | WO2003049767A3 Method of large scale production of hepatitis a virus |
| 03/11/2004 | WO2003047532A3 Compositions and methods for the therapeutic use of an atonal-associated sequence for a gastrointestinal condition |
| 03/11/2004 | WO2003042374A3 Isolation of neurones and stem cells for nerve fibres from a sample |
| 03/11/2004 | WO2003040337A3 Polyamide modulators of cox2 transcription |
| 03/11/2004 | WO2003035878A3 Lipase variants |
| 03/11/2004 | WO2003029288A3 Polypeptides derived from inducible hsp70 and pharmaceutical compositions containing the same |
| 03/11/2004 | WO2003026479A3 Methods of suppressing microglial activation |
| 03/11/2004 | WO2003025116A3 Method for increasing the solubility, expression rate and the activity of proteins during recombinant production |
| 03/11/2004 | WO2003018799A3 Modulators of bone homeostasis identified in a high-throughput screen |
| 03/11/2004 | WO2003013431A3 Compositions and methods for the therapy and diagnosis of breast cancer |
| 03/11/2004 | WO2003012393A3 Method of detecting protease activity in a cell |
| 03/11/2004 | WO2003008548A3 Mouse farnesoid x receptor sequences for use in comparative pharmacology |
| 03/11/2004 | WO2003007873A3 Plasma protein matrices and methods for their preparation |
| 03/11/2004 | WO2003004600A3 Improvement of viral uptake into cells and tissues |
| 03/11/2004 | WO2002099063A8 Alteration of embryo/endosperm size during seed development |
| 03/11/2004 | WO2002099050A3 Tprs as modifiers of the p53 pathway and methods of use |
| 03/11/2004 | WO2002095068A3 Engineered secreted alkaline phosphatase (seap) reporter genes and polypeptides |
| 03/11/2004 | WO2002083709A3 Kinases and phosphatases |
| 03/11/2004 | WO2002079441A3 Secreted proteins |
| 03/11/2004 | WO2002076337A3 Xenograft bone matrix for orthopedic applications |
| 03/11/2004 | WO2002072802A3 Live attenuated strains of prrs virus |
| 03/11/2004 | WO2002062135A8 Scce modified transgenic mammals and their use as models of human disease |
| 03/11/2004 | US20040049819 Soybean cultivar SN83544 |
| 03/11/2004 | US20040049818 Producing a soybean plant produced by crossing the cultivar with itself or another soybean variety; hybrid soybean seeds and plants produced by crossing the cultivar and another cultivar |
| 03/11/2004 | US20040049017 A protein complex which includes a growth factor, growth factor binding protein and vitronectin; for treating cancers, psoriasis, atherosclerosis and wounds prone to hypertrophic scarring |
| 03/11/2004 | US20040049016 The glycoproteins induce apoptosis and can be used as a therapeutic agent against Flavivirus infection and cancer |
| 03/11/2004 | US20040049014 Production of non-immunogenic antibodies having strong affinity for a predetermined antigen |
| 03/11/2004 | US20040048824 Antisense modulation of fibroblast growth factor receptor 3 expression |
| 03/11/2004 | US20040048819 Complexes for transferring nucleic acids into cells |
| 03/11/2004 | US20040048798 Especially CTL polypeptides of specific sequences |
| 03/11/2004 | US20040048796 Collagen biofabric and methods of preparation and use therefor |
| 03/11/2004 | US20040048377 Methods and compositions involved in groucho-mediated differentiation |
| 03/11/2004 | US20040048375 Transformation of pluripotential stem cells to perform highly specific functions for replacement or repair of dead or failing tissue in body organs such as the heart, brain, liver, kidney or pancreas |
| 03/11/2004 | US20040048374 Obtained by transferring a cell proliferation factor gene located between a pair of site-specific recombination sequences into a mammalian liver cell |
| 03/11/2004 | US20040048373 Production and long-term in vitro culture of these cell populations, and the use of neuroblasts in the treatment of various neuronal disorders as well as the identification of compositions which affect neuroblasts |
| 03/11/2004 | US20040048372 Extracting and recovering embryonic-like stem cells, including pluripotent or multipotent stem cells, from an exsanguinated human placenta; use of the isolated and perfused placenta as a bioreactor in which to propagate endogenous/exogenous cells |
| 03/11/2004 | US20040048371 Comprises packaging the biological material, altering the original atmosphere associated with the biological material to reduce the level of oxygen the material is exposed to and subjecting the packaged material to irradiation |
| 03/11/2004 | US20040048370 Cell targeting methods and compositions |
| 03/11/2004 | US20040048368 Polypeptide production in animal cell culture |
| 03/11/2004 | US20040048365 Nanotube mats for supporting, organizing, growing or interfacing biological cells, cell processes or agents |
| 03/11/2004 | US20040048353 Helicobacter pylori proteins useful for vaccines and diagnostics |
| 03/11/2004 | US20040048352 Immortal avian cells |
| 03/11/2004 | US20040048338 IL-17 receptor like molecules and uses thereof |
| 03/11/2004 | US20040048335 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/11/2004 | US20040048334 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/11/2004 | US20040048333 Membrane/fusion proteins; PRO polypeptides; immunoglobulins; solid phase synthesis; for modulating uptake of glucose by skeletal muscle cells |
| 03/11/2004 | US20040048331 For detection of mammalian tumors; for production of Lewis Y antigens; tumor associated antigens; immunoassay; rep genes/proteins; fusion proteins |
| 03/11/2004 | US20040048319 Activated leukocyte cell adhesion molecule (ALCAM); immunoglobulins; membrane proteins; for controlling neovascularization; anticancer agents; immunotherapy |
| 03/11/2004 | US20040048312 Antibodies that bind to integrin alpha-v-beta-6 and methods of use thereof |
| 03/11/2004 | US20040048303 Alzheimer's disease secretase, APP substrates therefor, and uses therefor |
| 03/11/2004 | US20040048294 Diagnostic and therapeutic methods useful for diagnosing and treating diseases, disorders, and/or conditions related to these novel human secreted proteins |
| 03/11/2004 | US20040048293 Useful for obtaining tumour-selective gene expression in tumours having a mutated beta -catenin pathway; used to express genes encoding therapeutic proteins in colorectal cancer cells |
| 03/11/2004 | US20040048288 Novel nucleic acids and polypeptides related to a guanine exchange factor of Rho GTPase |
| 03/11/2004 | US20040048280 A polynucleotide that includes an endothelial specific enhancer element |
| 03/11/2004 | US20040048277 Eukaryotic cell division genes and their use in diagnosis and treatment of proliferative diseases |
| 03/11/2004 | US20040048266 Regulation of human membrane-type serine protease |
| 03/11/2004 | US20040048256 Isolated polypeptide of given sequence; use in screening for identifying therapeutic antibodies and drugs |
| 03/11/2004 | US20040048245 Isolated polypeptide of given sequence; identifying modulators by contacting with compound and detecting binding activity; use in diagnosis and treatment |
| 03/11/2004 | US20040047890 Containing the viable cells, or tissue comprising the viable cells, prior to transplantation within a device comprising a semipermeable membrane; treating subject with a substance which inhibits an immune-system costimulation |
| 03/11/2004 | US20040047880 Component for vaccine |
| 03/11/2004 | US20040047848 Induction of immunological tolerance |
| 03/11/2004 | US20040047845 Methods and compositions for diagnosis and treatment of cancer based on the transcription factor ets2 |
| 03/11/2004 | US20040047843 Method for spinal cord reconnection in a damaged spinal cord which includes disposing white matter stem cells or cells capable of developing characteristics of neuronal or supporting cells in an area of spinal cord damage in a |
| 03/11/2004 | US20040047837 An autologous vaccine to tumor cells is produced by transducing the tumor cells with a herpes virus amplicon containing the gene for an immunomodulatory protein to provide transient expression of the immunomodulatory protein |
| 03/11/2004 | DE10240603A1 Verwendung von Malat-Dehydrogenase zur NADH-Regenerierung Use of malate dehydrogenase for NADH regeneration |
| 03/11/2004 | CA2497047A1 Adzymes and uses thereof |
| 03/11/2004 | CA2496950A1 Bioreactor with expandable surface area for culturing cells |
| 03/11/2004 | CA2496885A1 Method of diagnosing colon and gastric cancers |
| 03/11/2004 | CA2496789A1 Methods for preserving organs and tissues |
| 03/11/2004 | CA2496620A1 Non-human herpesviruses as vectors |
| 03/11/2004 | CA2496502A1 Generation of dendritic cells from cd34+ precursors |
| 03/11/2004 | CA2495882A1 Agents and methods for enhancing bone formation |
| 03/11/2004 | CA2494981A1 Production of multimeric fusion proteins using a c4bp scaffold |
| 03/11/2004 | CA2494772A1 Circular nucleic acid vectors, and methods for making and using the same |
| 03/11/2004 | CA2494450A1 Enriched central nervous system stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for such populations |
| 03/10/2004 | EP1396542A2 Novel P-selectin ligand protein |
| 03/10/2004 | EP1396501A1 Antibodies for identifying and/or isolating at least one cell population which is selected from the group comprising haematopoietic stem cells, neuronal stem cells, neuronal precursor cells, mesenchymal stem cells and mesenchymal precursor cells |
| 03/10/2004 | EP1395826A1 Antigen binding fragments for dendritic cell subset and use thereof |
| 03/10/2004 | EP1395684A2 New polynucleotides and polypeptides of the ifnalpha-7 gene |